All tenders
75N93024C00070
THE PRIMARY GOAL IS THE DELINEATION OF FUNCTIONAL B CELL EPITOPES RECOGNIZED BY POTENTLY NEUTRALIZING OR PROTECTIVE ANTIBODIES TO FACILITATE FUTURE DEVELOPMENT OF SAFE AND EFFECTIVE VACCINES AND THERAPEUTICS.
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75N93024C00070
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- THE PRIMARY GOAL IS THE DELINEATION OF FUNCTIONAL B CELL EPITOPES RECOGNIZED BY POTENTLY NEUTRALIZING OR PROTECTIVE ANTIBODIES TO FACILITATE FUTURE DEVELOPMENT OF SAFE AND EFFECTIVE VACCINES AND THERAPEUTICS.
- Source
- USASpending (Federal)
- Source ID
- usa-75N93024C00070
Details
- Location
- United States
Description
THE PRIMARY GOAL IS THE DELINEATION OF FUNCTIONAL B CELL EPITOPES RECOGNIZED BY POTENTLY NEUTRALIZING OR PROTECTIVE ANTIBODIES TO FACILITATE FUTURE DEVELOPMENT OF SAFE AND EFFECTIVE VACCINES AND THERAPEUTICS. Awarded to: WASHINGTON UNIVERSITY, THE Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2024/09/16 12:00:00 AM UTC
- Closing date
- 2027/09/15 12:00:00 AM UTC
Estimated value
$5.5M USD
Classification
Normalized category
Healthcare & Medical